Literature DB >> 17470917

West Nile virus: strategies for predicting municipal-level infection.

Nikolaos W Yiannakoulias1, Lawrence W Svenson.   

Abstract

The appearance and spread of West Nile virus (WNv) in North America represent a recent example of how mosquito-borne diseases can develop in new settings. Understanding the epidemiological, biological, and geographical aspects of WNv is critical to developing a greater understanding of how newly emerging, migrating, or evolving vector-borne infectious disease can develop globally. To aid in the allocation of resources that mitigate future outbreaks and to better understand the geographic nature of WNv in the North American prairies, we employ spatial and nonspatial modeling methods to predict municipal-level risk of human WNv infection rates. We use data based on a combination of routinely collected electronic data sources. Our findings suggest general agreement between spatial and nonspatial approaches, and results are consistent with seroprevalence-based estimates. We suggest that spatial models based on administrative data can offer estimates of relative risk in human populations at less cost, and in a timelier manner than estimates based on serology specimens.

Entities:  

Mesh:

Year:  2007        PMID: 17470917     DOI: 10.1196/annals.1408.010

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Dry weather induces outbreaks of human West Nile virus infections.

Authors:  Guiming Wang; Richard B Minnis; Jerrold L Belant; Charles L Wax
Journal:  BMC Infect Dis       Date:  2010-02-24       Impact factor: 3.090

Review 2.  Emerging viral zoonoses: frameworks for spatial and spatiotemporal risk assessment and resource planning.

Authors:  Archie C A Clements; Dirk U Pfeiffer
Journal:  Vet J       Date:  2008-08-20       Impact factor: 2.688

3.  Ecological niche of the 2003 west nile virus epidemic in the northern great plains of the United States.

Authors:  Michael C Wimberly; Michael B Hildreth; Stephen P Boyte; Erik Lindquist; Lon Kightlinger
Journal:  PLoS One       Date:  2008-12-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.